Is your child currently experiencing moderately to severely active IBD flare-ups? Local research is testing a potential new medication to see if it may reduce bloody diarrhea, unexplained weight loss, bloody stool, weight loss, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease research study to help us discover more about treating Crohn’s disease. If you are looking for a potential new treatment option for Crohn’s disease or moderately to severely active ulcerative colitis (including associated symptoms such as chronic diarrhea, mouth sores, rectal pain, malnutrition and/or canker sores), consider one of our GI clinical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing UC flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce abdominal pain or cramping, inflammation of the bowel or intestine, cramps, weight loss, and/or liver disease associated with UC.
If you’re concerned about how UC affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrolling for a limited time.

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease (CD) clinical trial to help us discover more about treating moderate to severe CD. If you are looking for a potential new treatment option for moderate to severe CD or Crohn’s disease (including associated symptoms such as rectal bleeding, joint pain, abdominal pain, chronic fatigue and/or canker sores), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing Crohn’s disease flare-ups? Local CD research study is testing a potential new medication to see if it may reduce fever, kidney stones, cramps, frequent fevers, and/or eye pain associated with Crohn’s disease.
If you’re concerned about how Crohn’s disease affects your child’s life, find out more about the CD research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children 2–17 years of age to join a study to help us discover more about treating Crohn’s disease (CD). If you are looking for a potential new treatment option for Crohn’s disease (CD) or moderate to severe ulcerative colitis (including associated symptoms such as cramps, loss of appetite, diarrhea, weight loss and/or anemia), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing Crohn’s disease (CD) flare-ups? Local Crohn’s disease clinical research study is testing a potential new medication to see if it may reduce weight loss, reduced appetite, diarrhea, weight loss, and/or eye pain associated with Crohn’s disease (CD).
If you’re concerned about how Crohn’s disease (CD) affects your child’s life, find out more about the Crohn’s disease clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children 2 to 17 years old to join a clinical research study to help us discover more about treating moderate to severe UC. If you are looking for a potential new treatment option for moderate to severe UC or moderate to severe Crohn’s disease (including associated symptoms such as fatigue, diarrhea, cramps, frequent fevers and/or eye pain), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing Crohn’s flare-ups? Local clinical research study is testing a potential new medication to see if it may reduce abdominal pain and cramps, fatigue, constant need to poop, chronic fatigue, and/or joint pain associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for children and teenagers 2–17 years of age to join a Crohn’s disease study to help us discover more about treating ulcerative colitis. If you are looking for a potential new treatment option for ulcerative colitis or moderately to severely active ulcerative colitis (including associated symptoms such as recurrent diarrhea, iron deficiency, rectal pain, frequent fevers and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.